Am J Transplant, Volume 19, Suppl 3 Archives - Page 62 of 214 - ATC Abstracts

2019 American Transplant Congress
Post-Transplant Functional Status Trajectory among Adult Kidney Transplant Recipients
N. Chu, Z. Shi, H. Ying, C. Haugen, D. Segev, M. McAdams-DeMarco
Johns Hopkins University, Baltimore, MD
*Purpose: Frailty and disabilities are highly prevalent among kidney transplant (KT) recipients, but are not routinely measured in KT recipients. The Karnofsky Performance Scale (KPS)…
2019 American Transplant Congress
Better Education of Kidney Recipients and Improved Access for Donor Referrals May Lead to Higher Living Donation Rates: An Early Single Center Analysis
V. Humphreville, N. Sarabu, M. DebRoy, M. Schuster, E. Sanchez, A. Padiyar, A. Jittirat, K. Yadav, J. Rabets, A. Palanisamy, K. Chavin
University Hospitals Cleveland Medical Center, Cleveland, OH
*Purpose: Disparity between the kidney waitlist and organs available continues to increase. Increasing living kidney donation may provide a solution to decreasing disparity.*Methods: In 2018…
2019 American Transplant Congress
Impact of Discards for Living Donor Kidney Transplantation in Center Transplant Program
H. Villafuerte¹, E. De Sousa-Amorim², L. Peri³, M. Musquera³, E. Palou⁴, M. Lozano⁵, J. Cid⁵, J. Martorell⁴, J. M. Campistol², F. Oppenheimer², F. Diekmann², I. Revuelta²
¹Department of Nephrology, Hospital Clinic Lozano Blesa, Zaragoza, Spain, ²Department of Nephrology and Kidney Transplant, Hospital Clinic, Barcelona, Spain, ³Department of Urology, Hospital Clinic, Barcelona, Spain, ⁴Department of Immunology, Hospital Clinic, Barcelona, Spain, ⁵Department of Apheresis, Hospital Clinic, Barcelona, Spain
*Purpose: New and coming information about the risk of living kidney donors make the effort to study very carefully the option of living kidney donor…
2019 American Transplant Congress
Early Cognitive Improvement One Month after Liver Transplant Measured by the NIH Toolbox
M. Kim¹, J. D. Peipert², K. J. Reid¹, E. M. Liotta¹, M. B. Maas¹, D. R. Ganger³, P. C. Zee¹, D. P. Ladner⁴
¹Neurology, Northwestern University, Chicago, IL, ²Medical Social Sciences, Northwestern University, Chicago, IL, ³Medicine, Northwestern University, Chicago, IL, ⁴Surgery, Northwestern University, Chicago, IL
*Purpose: Cognitive impairment (CI) is highly prevalent in liver cirrhosis. Improvement after liver transplant (LT) varies among patients, diminishing the benefits of LT for some.…
2019 American Transplant Congress
Multimodal Analgesia Reduces Opioid Use after Liver Transplantation
K. Tong, W. Nolan, D. O'Sullivan, H. Kutzler
Hartford Hospital, Hartford, CT
*Purpose: The study aimed to determine if multi-modal pain management (MPM) can reduce opioid use in patients post-liver transplant.*Methods: This was a retrospective review of…
2019 American Transplant Congress
The Experience of Somatostatin to Prevent Small-for-Size Syndrome in Patients with Small Graft in Living Donor Liver Transplantation
D. Kim, K. Yoon, H. Jo, W. Kang
Korea University College of Medicine, Seoul, Korea, Republic of
*Purpose: The small-for-size syndrome has to be overcome especially in living donor liver transplantation (LDLT) considering the graft and patient survival and morbidities. We introduce…
2019 American Transplant Congress
Management of Orphan Ducts After Pediatric Living Donor Liver Transplantation
N. Celik¹, A. Ganoza², A. Khanna², G. Bond², K. Soltys², R. Sindhi², J. Crowley³, A. Humar¹, G. Mazariegos²
¹Thomas E. Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, ²Hillman Center for Pediatric Transplantation, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA, ³Department of Radiology, Children's Hospital of Pittsburgh of UPMC, Pittsburgh, PA
*Purpose: Living donor (LDLT) and split (SLT) livers are two technical variants of standard liver transplants that potentially increase the number of liver allografts available…
2019 American Transplant Congress
Bespoke Immunosuppression: Prolonging Transplant Survival through Enhanced T-cell Activation Induced Cell Death
R. Costello¹, R. J. Ingram¹, D. Longley², J. McDaid³
¹WWIEM, QUB, Belfast, United Kingdom, ²CCRCB, QUB, Belfast, United Kingdom, ³Renal Transplantation, Belfast City Hospital, Belfast, United Kingdom
*Purpose: We aim to develop donor-specific immunosuppression by inhibiting T-cell cellular FLICE like inhibitory protein (c-FLIP). Our current work focuses on clinically relevant pharmacological inhibitors…
2019 American Transplant Congress
Alteration in Local Complement Activation in First 24h Post-Lung Transplantation (LTx) Helps Identify Recipients Developing Primary Graft Dysfunction
H. Kulkarni¹, M. Elvington², L. Ma¹, M. Cano¹, K. Pugh³, R. Hachem¹, J. Atkinson², A. Gelman³
¹Pulmonary and Critical Care Medicine, Washington University, Saint Louis, MO, ²Rheumatology, Washington University, Saint Louis, MO, ³Surgery, Washington University, Saint Louis, MO
*Purpose: Primary graft dysfunction (PGD) is a form of acute lung injury driven by ischemia-reperfusion mediated damage. An increase in plasma complement proteins - specifically…
2019 American Transplant Congress
The Clinical Outcomes of Kidney Transplant Recipients with Early Graft Failure: A Nationwide Study in South Korea
Y. Kim¹, S. Kwon¹, S. Park¹, J. Moon¹, J. Seon¹, J. Kim¹, M. Yu², K. Han³, D. Kim¹, Y. Kim¹, H. Lee¹
¹Internal Medicine, Seoul National University Hospital, Seoul, Korea, Republic of, ²Internal Medicine, Hanyang University Medical Center, Seoul, Korea, Republic of, ³Medical Statistics, Catholic University of Korea, Seoul, Korea, Republic of
*Purpose: Despite the graft outcome has been steadily improved over the years, early graft failure (EGF) poses a significant threat to kidney transplant (KT) recipients.…